Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) has provided an announcement.
Theracryf PLC has announced a change in its voting rights structure due to Spreadex LTD’s acquisition or disposal of voting rights and financial instruments. This notification indicates that Spreadex LTD now holds a total of 3.8998% of voting rights in Theracryf PLC, with 3.757% through direct voting rights and 0.1428% through financial instruments. This adjustment in holdings could potentially impact the company’s governance and stakeholder dynamics, reflecting a shift in shareholder influence.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 3,585,236
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.79M
For an in-depth examination of TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue